• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国新冠疫苗的公共卫生影响:观察性研究。

Public health impact of covid-19 vaccines in the US: observational study.

机构信息

Coronavirus Disease (COVID-19) Response, Centers for Disease Control and Prevention, Atlanta, GA, USA

Coronavirus Disease (COVID-19) Response, Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

BMJ. 2022 Apr 27;377:e069317. doi: 10.1136/bmj-2021-069317.

DOI:10.1136/bmj-2021-069317
PMID:35477670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9044401/
Abstract

OBJECTIVE

To evaluate the impact of vaccine scale-up on population level covid-19 mortality and incidence in the United States.

DESIGN

Observational study.

SETTING

US county level case surveillance and vaccine administration data reported from 14 December 2020 to 18 December 2021.

PARTICIPANTS

Residents of 2558 counties from 48 US states.

MAIN OUTCOME MEASURES

The primary outcome was county covid-19 mortality rates (deaths/100 000 population/county week). The secondary outcome was incidence of covid-19 (cases/100 000 population/county week). Incidence rate ratios were used to compare rates across vaccination coverage levels. The impact of a 10% improvement in county vaccination coverage (defined as at least one dose of a covid-19 vaccine among adults ≥18 years of age) was estimated During the eras of alpha and delta variant predominance, the impact of very low (0-9%), low (10-39%), medium (40-69%), and high (≥70%) vaccination coverage levels was compared.

RESULTS

In total, 30 643 878 cases of covid-19 and 439 682 deaths associated with covid-19 occurred over 132 791 county weeks. A 10% improvement in vaccination coverage was associated with an 8% (95% confidence interval 8% to 9%) reduction in mortality rates and a 7% (6% to 8%) reduction in incidence. Higher vaccination coverage levels were associated with reduced mortality and incidence rates during the eras of alpha and delta variant predominance.

CONCLUSIONS

Higher vaccination coverage was associated with lower rates of population level covid-19 mortality and incidence in the US.

摘要

目的

评估疫苗接种规模扩大对美国人群 COVID-19 死亡率和发病率的影响。

设计

观察性研究。

设置

2020 年 12 月 14 日至 2021 年 12 月 18 日期间,美国县一级病例监测和疫苗接种数据报告。

参与者

来自美国 48 个州的 2558 个县的居民。

主要观察指标

主要结局指标为县 COVID-19 死亡率(每 10 万人/县周死亡人数)。次要结局指标为 COVID-19 发病率(每 10 万人/县周病例数)。采用发病率比值比较不同疫苗接种覆盖率水平的发病率。估计了县疫苗接种覆盖率提高 10%(定义为≥18 岁成年人至少接种一剂 COVID-19 疫苗)的影响。在阿尔法和德尔塔变异体占主导地位的时期,比较了极低(0-9%)、低(10-39%)、中(40-69%)和高(≥70%)疫苗接种覆盖率水平的影响。

结果

总共发生了 30643878 例 COVID-19 病例和 439682 例与 COVID-19 相关的死亡病例,涉及 132791 个县周。疫苗接种覆盖率提高 10%与死亡率降低 8%(95%置信区间 8%-9%)和发病率降低 7%(6%-8%)相关。在阿尔法和德尔塔变异体占主导地位的时期,较高的疫苗接种覆盖率与死亡率和发病率的降低相关。

结论

较高的疫苗接种覆盖率与美国人群 COVID-19 死亡率和发病率的降低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/7fb72107d365/suta069317.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/c5c500025496/suta069317.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/0a8232c240a7/suta069317.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/a132c4468bb1/suta069317.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/7fb72107d365/suta069317.f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/c5c500025496/suta069317.f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/0a8232c240a7/suta069317.f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/a132c4468bb1/suta069317.f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56ae/9044401/7fb72107d365/suta069317.f4.jpg

相似文献

1
Public health impact of covid-19 vaccines in the US: observational study.美国新冠疫苗的公共卫生影响:观察性研究。
BMJ. 2022 Apr 27;377:e069317. doi: 10.1136/bmj-2021-069317.
2
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗对美国新冠肺炎发病率和死亡率的影响。
PLoS One. 2024 Apr 24;19(4):e0301830. doi: 10.1371/journal.pone.0301830. eCollection 2024.
3
Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021.2021 年 4 月至 6 月,科罗拉多州梅萨县 SARS-CoV-2 B.1.617.2(德尔塔)变异株传播迅速增加。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1084-1087. doi: 10.15585/mmwr.mm7032e2.
4
Relationship between COVID-19 cases and vaccination rates in New York State counties.纽约州各县的 COVID-19 病例与疫苗接种率之间的关系。
Ann Fam Med. 2022 Apr 1;20(20 Suppl 1):3134. doi: 10.1370/afm.20.s1.3134.
5
Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.模型估计的美国小学相关 SARS-CoV-2 传播、缓解干预措施与疫苗接种率之间的关联,按当地发病水平分类。
JAMA Netw Open. 2022 Feb 1;5(2):e2147827. doi: 10.1001/jamanetworkopen.2021.47827.
6
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.mRNA 新冠疫苗在美国退伍军人中的接种率和预估有效性。
JAMA Netw Open. 2021 Oct 1;4(10):e2128391. doi: 10.1001/jamanetworkopen.2021.28391.
7
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.SARS-CoV-2 感染和≥18 岁成年人住院情况,按疫苗接种状态,在 SARS-CoV-2 B.1.1.529(奥密克戎)变异株流行之前和期间——加利福尼亚州洛杉矶县,2021 年 11 月 7 日-2022 年 1 月 8 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 4;71(5):177-181. doi: 10.15585/mmwr.mm7105e1.
8
Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.美国接种 SARS-CoV-2 疫苗后报告的严重不良事件分析:一年后。
Front Public Health. 2022 Oct 13;10:972464. doi: 10.3389/fpubh.2022.972464. eCollection 2022.
9
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.城乡地区 COVID-19 疫苗接种覆盖率差距 - 美国,2020 年 12 月 14 日-2021 年 4 月 10 日。
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):759-764. doi: 10.15585/mmwr.mm7020e3.
10
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.新冠病毒疫苗接种与儿童感染新冠病毒及住院的发生率
JAMA Netw Open. 2024 Apr 1;7(4):e247822. doi: 10.1001/jamanetworkopen.2024.7822.

引用本文的文献

1
Rural-Urban Disparities in COVID-19 Vaccine Uptake and Associated Mortality and Cardiovascular Disease Outcomes in the United States.美国城乡在新冠疫苗接种率以及相关死亡率和心血管疾病结局方面的差异
Vaccines (Basel). 2025 Aug 14;13(8):861. doi: 10.3390/vaccines13080861.
2
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy.新冠疫苗接种仍有意义:来自意大利一家学术三级中心的大规模研究对肺炎风险和住院情况的见解
Microorganisms. 2025 Jul 25;13(8):1744. doi: 10.3390/microorganisms13081744.
3
COVID-19 vaccination status and factors associated with deaths from the disease, Vitória, 2020-2023: cross-sectional study.

本文引用的文献

1
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗对美国新冠肺炎发病率和死亡率的影响。
PLoS One. 2024 Apr 24;19(4):e0301830. doi: 10.1371/journal.pone.0301830. eCollection 2024.
2
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.美国奥密克戎、德尔塔和阿尔法 SARS-CoV-2 变异株的 mRNA 疫苗对新冠病毒的临床严重程度和有效性:前瞻性观察研究。
BMJ. 2022 Mar 9;376:e069761. doi: 10.1136/bmj-2021-069761.
3
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants.
2020 - 2023年维多利亚市新冠病毒病疫苗接种状况及与该病死亡相关的因素:横断面研究
Epidemiol Serv Saude. 2025 Aug 8;34:e20240700. doi: 10.1590/S2237-96222025v34e20240700.en. eCollection 2025.
4
Effect of COVID-19 vaccination on the incidence, lethality and mortality of pregnant and postpartum women.新冠病毒疫苗接种对孕妇和产后妇女发病率、致死率及死亡率的影响。
PLoS One. 2025 Jul 8;20(7):e0327207. doi: 10.1371/journal.pone.0327207. eCollection 2025.
5
Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine.用于测量接种新冠疫苗意愿的单项量表的辨别力。
PLoS One. 2025 May 5;20(5):e0322503. doi: 10.1371/journal.pone.0322503. eCollection 2025.
6
Using machine learning to identify COVID-19 vaccine-hesitancy predictors in the USA.利用机器学习识别美国新冠疫苗犹豫的预测因素。
BMJ Public Health. 2023 Dec 17;1(1):e000456. doi: 10.1136/bmjph-2023-000456. eCollection 2023 Nov.
7
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice.携带受体结合域(RBD)突变的信使核糖核酸(mRNA)疫苗对小鼠体内的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体具有广谱活性。
NPJ Vaccines. 2025 Jan 13;10(1):7. doi: 10.1038/s41541-025-01066-4.
8
Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease.新型冠状病毒2型主要蛋白酶对人tRNA甲基转移酶TRMT1的识别与切割
Elife. 2025 Jan 7;12:RP91168. doi: 10.7554/eLife.91168.
9
Vaccine equity implementation: exploring factors influencing COVID-19 vaccine delivery in the Philippines from an equity lens.疫苗公平性实施:从公平视角探讨菲律宾 COVID-19 疫苗接种的影响因素。
BMC Public Health. 2024 Nov 5;24(1):3058. doi: 10.1186/s12889-024-20578-7.
10
COVID-19 and multiple sclerosis: challenges and lessons for patient care.2019冠状病毒病与多发性硬化症:患者护理面临的挑战与经验教训
Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep.
mRNA-1273 对 SARS-CoV-2 奥密克戎和德尔塔变异株的有效性。
Nat Med. 2022 May;28(5):1063-1071. doi: 10.1038/s41591-022-01753-y. Epub 2022 Feb 21.
4
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.SARS-CoV-2 变体的基因组监测:Delta(B.1.617.2)和奥密克戎(B.1.1.529)变体占主导地位-美国,2021 年 6 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):206-211. doi: 10.15585/mmwr.mm7106a4.
5
County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.美国县级新冠疫苗接种覆盖率以及新冠病例和死亡发生率:一项生态分析。
Lancet Reg Health Am. 2022 May;9:100191. doi: 10.1016/j.lana.2022.100191. Epub 2022 Jan 31.
6
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中,在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区,2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
7
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.新冠疫苗接种对阿尔法和德尔塔变异株传播的影响。
N Engl J Med. 2022 Feb 24;386(8):744-756. doi: 10.1056/NEJMoa2116597. Epub 2022 Jan 5.
8
Coronavirus Disease Case Definitions, Diagnostic Testing Criteria, and Surveillance in 25 Countries with Highest Reported Case Counts.25 个报告病例最多的国家的冠状病毒病病例定义、诊断检测标准和监测。
Emerg Infect Dis. 2022 Jan;28(1):148-156. doi: 10.3201/eid2801.211082.
9
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.估计美国 COVID-19 疫苗接种计划对 65 岁及以上成年人 COVID-19 病例、急诊就诊、住院和死亡的早期影响:国家监测数据的生态分析。
Lancet. 2022 Jan 8;399(10320):152-160. doi: 10.1016/S0140-6736(21)02226-1. Epub 2021 Nov 3.
10
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.在以色列全国范围内使用辉瑞-生物科技公司的 BNT162b2 mRNA COVID-19 疫苗进行疫苗接种运动,以预防感染、住院和死亡:一项回顾性监测研究。
Lancet Infect Dis. 2022 Mar;22(3):357-366. doi: 10.1016/S1473-3099(21)00566-1. Epub 2021 Sep 22.